ChiCTR2100048734: Safety and Effectiveness of Lonasen Post-marketing Surveillance in Treatment of Chinese Schizophrenia Patients |
|
|
| Recruiting | 4 | 3000 | | Nil | The Second Xiangya Hospital of Central South University; Sumitomo Pharmaceutical (Suzhou) Co., Ltd., Sumitomo Pharmaceutical (Suzhou) Co., Ltd. | Schizophrenia | | | | |
NCT03784222: Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients |
|
|
| Terminated | 4 | 102 | RoW | Blonanserin, MRI and serum BDNF | Sumitomo Pharma (Suzhou) Co., Ltd. | First Episode Schizophrenia, Social Function, Cognition Function, Blonanserin | 11/22 | 11/22 | | |
